Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

5,610JPY
15 Feb 2019
Change (% chg)

¥-140 (-2.43%)
Prev Close
¥5,750
Open
¥5,690
Day's High
¥5,710
Day's Low
¥5,600
Volume
71,600
Avg. Vol
141,440
52-wk High
¥7,350
52-wk Low
¥4,260

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 16 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 3 3 4
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.12 2.12 2.11

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-19 8 22,206.60 23,600.00 21,500.00 22,109.00
Year Ending Mar-20 8 25,091.90 28,900.00 22,900.00 25,312.50
Earnings (per share)
Year Ending Mar-19 9 104.85 133.10 67.50 103.63
Year Ending Mar-20 9 143.93 224.10 99.60 143.29
LT Growth Rate (%) 1 26.66 26.66 26.66 43.08

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 5,472.00 5,346.00 126.00 2.30
Quarter Ending Dec-17 5,200.00 5,061.00 139.00 2.67
Quarter Ending Sep-17 5,300.00 5,801.00 501.00 9.45
Quarter Ending Mar-15 4,311.00 4,539.00 228.00 5.29
Quarter Ending Dec-14 3,950.00 4,160.95 210.95 5.34

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-19 22,206.60 22,206.60 22,259.00 22,259.00 22,109.00
Year Ending Mar-20 25,091.90 25,091.90 25,106.40 25,106.40 25,312.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-19 0 0 0 1
Year Ending Mar-20 0 0 1 0
Earnings